A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
480
about 5 years
18+
7 sites in NJ, NY
About this study
This trial is testing whether a virtual mind-body program, Integrative Medicine at Home (IM@Home), will improve patients' perceived values, outcomes, and experiences during cancer treatment. It involves people with gynecologic cancer, gynecologic tumors, head and neck cancer, head and neck tumors, melanoma, ovarian cancer, thoracic cancer, or thoracic tumors. Participants will receive enhanced usual care along with the IM@HOME program.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Enhanced usual care
- 2.Receive IM@Home
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Average Fatigue Severity from the Brief Fatigue Inventory (BFI)
Secondary: Effect of treatments on psychological distress as measured by Hospital Anxiety and Depression Scale (HADS), Insomnia severity as measured by Insomnia Severity Index (ISI), Pain as measured by Patient Reported Outcomes Measurement Information System (PROMIS®) Scale v1.2 - Global Health, Symptom intensity as measured by Edmonton Symptom Assessment Scale (ESAS)
Oncology